Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Shalini Garg
IBS (Irritable Bowel Syndrome)
Delhi
This story is a powerful testament to resilience and hope. It narrates the journey of Shalini Gar…
Gaurav Kumar
Chronic Calcific Pancreatitis
Delhi
For over a decade, Gaurav Kumar was trapped in a relentless cycle of agony and hospitalization, b…
Avichal Dixit
Chronic Calcific Pancreatitis
Pilibhit, Uttar Pradesh
This narrative traces the rapid systemic degradation faced by Avichal Dixit, a talented young stu…
Ravinder Kumar
Recurrent Acute Pancreatitis, Diabetes
Panipat, Haryana
This story is a powerful testament to resilience and hope. It narrates the journey of Ravinder Ku…
Rohit Gupta
Chronic Pancreatitis
New Delhi
This is the story of Rohit Gupta , whose resilience transformed a seemingly insurmountable clinic…
Vivaan Guleria
Acute on Chronic Pancreatitis
Dharamshala, Himachal Pradesh
This story is a powerful testament to resilience and hope. It narrates the journey of Vivaan Gule…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Ayurvedic preparation in the treatment of nutritional anemia
A pilot study on 600 anemic women showed the highest hemoglobin gain (1.8 g%) with a combination of Ayurvedic preparations SS and Ayas, followed by Ayas (1.6 g%), SS (1.5 g%), and IFA tablets (1.1 g%). SS, a non-iron Ayurvedic preparation, improved iron absorption and showed promising results with minimal side effects.
Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial
A study on 250 patients compared the Ayurvedic formulation IMMBO to a levocetirizine-montelukast combination for allergic rhinitis. IMMBO showed significantly greater improvements in symptoms (TNSS: -5.70 vs. -3.31) and IgE reduction (-351.54 vs. -208.79), demonstrating superior efficacy and safety.
CA19-9 LOWERING EFFECT OF AN AYURVEDIC MINERAL COMPLEX PREPARED USING COPPER, MERCURY AND SULPHUR
Rasa Shastra, an Ayurvedic practice using metals and minerals, has shown that Ayurvedic Mineral Complex (AMC) helps reduce elevated CA19-9 levels in pancreatitis patients. This suggests AMC could be explored as a preventive therapy for pancreatic cancer.
Randomized Controlled Study to Evaluate Prophylactic Properties of Ayurvedic Treatment Protocol in Refractory and Chronic Migraine Patients
This study compared Ayurvedic treatment to conventional therapy for chronic refractory migraine. After 360 days, the Ayurvedic group showed greater reductions in headache days, VAS, and MIDAS scores (p
Anti-Inflammatory Properties of a Processed Copper Complex in L-Arginine Induced Pancreatitis-Two Experimental Studies
Recurrent Acute/Chronic Pancreatitis (RA/CP) is a progressive pancreatic inflammation, often with unclear causes. An Ayurvedic Mineral Complex (AMC) showed promise in reducing exacerbations and hospitalizations in pancreatitis patients. In a rat model, AMC was well tolerated, reduced oxidative stress and inflammation, and protected the pancreas at doses of 25 mg/kg and 19 mg/kg.
Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis
Hereditary pancreatitis (HP) is a chronic genetic disorder with limited treatment options. This study evaluated the efficacy of a year-long Ayurvedic Treatment Protocol (ATP) in 151 patients, 88 of whom completed the program. The treatment included Ayurvedic formulations, dietary adjustments, and discontinuation of pancreatic enzymes. Results showed a 92.8% reduction in attack frequency and a 98.7% decrease in hospitalizations (p < 0.0001), with no adverse effects. ATP demonstrated safety and effectiveness in managing HP, suggesting the need for further research.